AMBEV S.A. current report, Q2 FY2019

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the period ending June 30, 2019. The report serves as a notice of a capital increase approved by the Board of Directors on June 19, 2019, resulting from the exercise of stock options granted in 2010 under the Company's Stock Option Plan.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and historical share pricing.

MetricValue
Capital Increase AmountBRL 72,802.91
New Capital StockBRL 57,799,792,732.00
New Shares Issued32,200 common shares (no par value)
Issuance Price per ShareBRL 2.26096
Potential Dilution0.00020%

Material Changes

The primary material change is the issuance of 32,200 new common shares, increasing the total capital stock. This issuance was executed at a price significantly below the recent market average (BRL 2.26 issuance price vs. BRL 17.35 average over the last 90 days), consistent with the exercise of legacy stock options.

Guidance, Outlook, and Risks

The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a procedural disclosure regarding the verification of share issuance and the reporting of historical market prices for the Company's shares over the preceding three years.

Investor Verification Checklist

  • Verify the impact of the 0.00020% dilution on existing shareholder equity.
  • Confirm the total number of outstanding shares post-issuance against the new capital stock figure of BRL 57,799,792,732.00.
  • Review the historical share price data provided to understand the discount at which the options were exercised relative to market value.
  • Note that this filing does not contain operational or financial performance data for the period.